Responding to developments | Cutting through the noise | Promoting diverse voices | Shaping opinion | Making connections | Pointing to the evidence

Parallel pandemics: COVID-19 and the lessons for Antimicrobial Resistance

30th September 2021

While the COVID-19 pandemic has understandably hogged the headlines for the last few years, there is another, ‘slow-motion’ pandemic taking place at the same time: Antimicrobial Resistance (AMR). In this post, Dr Louise Sweeney, Consultant Medical Microbiologist, Liverpool, explores what COVID-19 can teach us when it comes to treating all infectious diseases…

Vanguard Report: The future role of laboratories in relation to antimicrobial resistance

28th September 2021

To celebrate our 50th anniversary, we’re inviting a select number of experts to share what they see as being the 21st-century solutions to one of the biggest and most complex challenges of our generation: antimicrobial resistance. In this post, David Wells explores the future role of laboratories in relation to antimicrobial resistance...

Mycology under the microscope: Why it’s time to bring fungal infections into the light

22nd September 2021

According to the Global Action Fund for Fungal Infection, over 300 million people around the world are afflicted with a serious fungal infection every year and 25 million are at high risk of dying or losing their sight. Yet there is a persistent sense that fungal infections receive neither the attention nor the funding afforded to infectious diseases caused by viruses or bacteria. With this in mind, we invited Gavin Barlow, Senior Clinical Lecturer in Infection at Hull York Medical School and Hon. Physician in Infectious Diseases, Hull University Teaching Hospitals, to explain why we mustn’t forget fungal infection…

Vanguard Report: Drug development and the tension between access and excess

21st September 2021

To celebrate our 50th anniversary, we’re inviting a select number of experts to share what they see as being the 21st-century solutions to one of the biggest and most complex challenges of our generation: antimicrobial resistance. In this post, Santanu Datta explores the future of drug development and the tension between access and excess…

UTIs: What are the burning issues?

9th September 2021

It’s estimated that around half of all women in the UK will suffer at least one urinary tract infection (UTI) at some point in their lives. Yet despite being the leading source of bacterial bloodstream infections, UTIs remain a chronically neglected area of infectious diseases. With that in mind, we invited Dr Annie Joseph, Consultant Microbiologist at Nottingham University Hospitals NHS Trust, to discuss what needs to happen so that UTIs, and patients, finally get the attention they deserve….

AMR risk: National blood tube shortage highlights vital importance of testing to fight infection

2nd September 2021

The UK Government is supporting action to alleviate the current national shortage of test tubes, which has resulted in widespread disruption to testing around the country.

Vanguard Report: The future of drug development

10th August 2021

To celebrate our 50th anniversary, we’re inviting a select number of experts to share what they see as being the 21st-century solutions to one of the biggest and most complex challenges of our generation: antimicrobial resistance. In this post, Laura Piddock explores the challenges involved in re-stimulating the antimicrobial drug development market…

What can we learn from Using Antibiotics Wisely to revamp future antibiotic campaigns?

20th July 2021

The Journal of Antimicrobial Chemotherapy (JAC) recently published on the Canadian antibiotic stewardship campaign ‘Using Antibiotics Wisely’. This national campaign did not have the desired effect of reducing antibiotic prescribing. Dr Oliver van Hecke was disappointed, but not surprised. Here, he explains why…

1 2 3
GP? Pharmacist? Researcher? Social Scientist? Whatever field you work in, if you’re committed to fighting infection then we want you to join us as a BSAC Member.
Become a member
I have read and agree to the Privacy Policy

Having trouble finding what you're after?

Top